The international guidelines for diagnosing multiple sclerosis (MS), known as the McDonald criteria, have undergone their most significant update in over a decade. This 2024 overhaul aims to modernize the framework used by clinicians worldwide to identify the autoimmune disease.
Early Detection Through Integrated Data
The revised criteria combine clinical observations with sophisticated imaging and laboratory findings. By leveraging these diverse data points, medical professionals may now be able to diagnose MS even before physical symptoms become apparent to the patient.
Global Expert Collaboration
The update was the result of extensive collaboration among international experts. Among the contributors was Dr. Jiwon Oh, director of the BARLO MS Centre at St. Michael's Hospital, who helped shape the new standards to ensure they reflect the latest scientific understanding of the disease's progression.
